ask="0.6400"
ask_size="6000"
average_daily_volume="140360"
bid="0.5850"
bid_size="9900"
book_value="0.7250"
change="+0.0079"
change_from_200_day_moving_average="-0.7310"
change_from_50_day_moving_average="-0.4792"
change_from_52_week_high="-1.3995"
change_From_52_week_low="0.0405"
change_in_percent="+1.3331%"
close="0.6005"
dividend_pay_date="11/8/2012"
dividend_per_share="0.0000"
dividend_yield="0.0000"
earnings_per_share="-0.8100"
ebitda="-30.60M"
eps_estimate_current_year="-0.9300"
eps_estimate_next_quarter="-0.2300"
eps_estimate_next_year="-0.8600"
ex_dividend_date="11/9/2012"
float_shares="30530000"
high="0.6100"
high_52_weeks="2.0000"
last_trade_date="3/1/2017"
last_trade_price="0.6005"
last_trade_size="742"
last_trade_time="4:00pm"
low="0.5600"
low_52_weeks="0.5600"
market_capitalization="23.21M"
moving_average_200_day="1.3315"
moving_average_50_day="1.0797"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.1700"
open="0.5700"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-54.9018%"
percent_change_from_50_day_moving_average="-44.3832%"
percent_change_from_52_week_high="-69.9750%"
percent_change_from_52_week_low="+7.2321%"
previous_close="0.5926"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.8174"
price_per_sales="2.3371"
revenue="9.80M"
shares_outstanding="38649000"
short_ratio="1.3700"
stock_exchange="NMS"
symbol="AVIR"
volume="160502"
weeks_range_52="0.5600 - 2.0000"
